Back to Search Start Over

7-Methoxyisoflavone ameliorates atopic dermatitis symptoms by regulating multiple signaling pathways and reducing chemokine production.

Authors :
Dong, Hao
Feng, Chenjie
Cai, Xiyunyi
Hao, Yuanyuan
Gu, Xinyue
Cai, Lei
Wu, Shuting
Chen, Jiamin
Liu, Zhou
Xie, Wen
Lu, Xuanren
Qian, Hongfa
Liu, Yulin
Cao, Yiming
Zhu, Junlin
Xu, Jiayi
Zhou, Yanjie
Ma, Shuangyu
Yang, Sha
Shi, Yufeng
Source :
Scientific Reports; 5/24/2022, Vol. 12 Issue 1, p1-15, 15p
Publication Year :
2022

Abstract

7-Met, a derivative of soybean isoflavone, is a natural flavonoid compound that has been reported to have multiple signaling pathways regulation effects. This study investigated the therapeutic effects of 7-Met on mice with atopic dermatitis induced by fluorescein isothiocyanate (FITC), or oxazolone (OXZ). 7-Met ameliorated FITC or OXZ-induced atopic dermatitis symptoms by decreasing ear thickness, spleen index, mast cell activation, neutrophil infiltration and serum IgE levels in female BALB/c mice. In FITC-induced atopic dermatitis mice, 7-Met reduced Th1 cytokines production and regulated Th1/Th2 balance by downregulating the secretion of thymic stromal lymphopoietin (TSLP) via inactivation of the NF-κB pathway. In OXZ-induced atopic dermatitis, 7-Met functioned through the reduction of Th17 cytokine production. Our study showed that 7-Methoxyisoflavone alleviated atopic dermatitis by regulating multiple signaling pathways and downregulating chemokine production. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
20452322
Volume :
12
Issue :
1
Database :
Complementary Index
Journal :
Scientific Reports
Publication Type :
Academic Journal
Accession number :
157055366
Full Text :
https://doi.org/10.1038/s41598-022-12695-3